Form 4 for CRL Charles River Laboratories
Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-04 · accession 0001127602-22-025053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-07 | 2022-11-04 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $216.36 | -534 | 20.2K | -3% | -$115.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-04 | S | D | 534 | $216.36 | 20,232 | D | — | — |